Quality Biological and JPT Peptide Technologies announce non-exclusive distribution and marketing agreement

Berlin, Germany and Gaithersburg, MD, USA – September 15, 2005:
JPT Peptide Technologies GmbH (JPT) the leading supplier of innovative peptide-based services and products based in Berlin and Quality Biological, Inc. (QBI) the US molecular biology lab supplies and products manufacturer, today announced the start of a non-exclusive distribution and marketing agreement for the USA. Within the scope of this agreement, the parties join forces to better serve customers in the US. Quality Biological, Inc. has a long history of superior customer service in the research marketplace, and this cooperation will enhance the numerous marketing activities underway and accelerate customer order processing with JPT. "I am delighted that we could win Quality Biological as distributor for our peptide-based products and services in America. They are part of the Mid-Atlantic scientific community; the scientists trust them and have relied on their products and support for decades. QBI, in turn, knows us and has helped process our highly explanation-prone products for selected customers for some time now. I am pleased that we can now offer the ease-of-mind they guarantee to all of our American customers." stated Peter-Paul Henze, JPT's Director of Sales and Marketing, who heads the US office of JPT in Springfield, VA. "JPT brings a wealth of experience and some very cutting-edge technologies to the table" says Sol Graham, President and CEO, of Quality Biological, Inc. "People think that peptides are a simple commodity, but our demanding clientele knows better and simply cannot afford to lose time or waste biological material, therefore we are pleased to partner with an innovative company which values its customers and provides quality products and services to the research community."

About JPT Peptide Technologies GmbH:

JPT Peptide Technologies is an ISO 9001:2000 certified biotechnology company based in Berlin and a leading supplier of innovative peptide-based services and products. JPT licensed and owns several proprietary technologies such as the high-throughput peptide synthesis and screening platform PepSpot™, the peptide microarray technology PepStar™, and PepMix™, a unique approach for antigen specific T-cell stimulation by antigen spanning peptide pools. JPT has a world-wide customer base throughout the pharmaceutical and biotechnology industries. JPT is a wholly-owned subsidiary of Jerini AG.

About Quality Biological, Inc.:

Quality Biological, Inc. (, founded in 1983, is a privately held company located in Gaithersburg, Maryland. Quality Biological provides products and lab supplies for the molecular biology laboratory (including buffers, and RNA and DNA reagents) and for the cell biology laboratory (including traditional cell culture media the QBSF® range of serum-free media, products for stem cell culture, hematopoiesis research, and custom manufacturing). Quality Biological has served customers in biomedical research for over two decades and has earned a superior reputation for excellent service and dependability within the scientific community. They have developed strong scientific relationships with leading scientists at all major federal and DoD research laboratories leading research and academic institutions around the world as well as the many Biotechnology start-up companies throughout the mid-Atlantic region.

For further information please contact:
JPT Peptide Technologies GmbH
Dr. Holger Wenschuh

Managing Director
Volmerstr. 5
12489 Berlin, Germany
Phone: +49 - 30 - 6392 – 5500
Fax: +49 - 30 - 6392 – 5501

Quality Biological, Inc.
Ronald L. Brown, PhD

Director, Research and Development
7581 Lindbergh Drive
USA - Gaithersburg, MD 20879
Phone: +1.301.840.8950
Fax: +1.301.840.5450

Stay in touch and be the first to receive the latest news!